Y
Yasushi Omuro
Researcher at Tokyo Metropolitan Komagome Hospital
Publications - 58
Citations - 7086
Yasushi Omuro is an academic researcher from Tokyo Metropolitan Komagome Hospital. The author has contributed to research in topics: Cancer & Ramucirumab. The author has an hindex of 16, co-authored 51 publications receiving 5899 citations. Previous affiliations of Yasushi Omuro include Anhui Medical University.
Papers
More filters
Journal ArticleDOI
TAS-118 (S-1 plus leucovorin) versus S-1 in gemcitabine-refractory advanced pancreatic cancer: A randomized, open-label, phase III trial (GRAPE trial).
Makoto Ueno,Tatsuya Ioka,Hideki Ueno,Joon Oh Park,Heung-Moon Chang,Naoki Sasahira,Masashi Kanai,Ik-Joo Chung,Masafumi Ikeda,Shoji Nakamori,Nobumasa Mizuno,Yasushi Omuro,Taketo Yamaguchi,Hiroki Hara,Kazuya Sugimori,Junji Furuse,Masahiro Takeuchi,Takuji Okusaka,Narikazu Boku,Ichinosuke Hyodo +19 more
TL;DR: This data indicates that addition of oral leucovorin to S-1 significantly improved progression-free survival in a previous randomized phase II trial in Japanese patients with gemcitabine with positive results for PFS.
Journal ArticleDOI
Pls-1a japanese subgroup analysis of the lapatinib for gastric cancer (tytan) study
Taroh Satoh,Toshihiko Doi,Akihito Tsuji,Yasushi Omuro,Hiroto Miwa,Tomohiro Nishina,Hirofumi Fujii,A. Mukaiyama,M. Kobayashi,A. Ohtsu,Nobuyuki Mizunuma +10 more
Journal ArticleDOI
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience].
Y. Yagi,Yusuke Kanemasa,Yuki Sasaki,Yudai Hayashi,Mano Mino,Chikai Kato,Satoshi Sakai,An Ohigashi,Yasuhiro Kanbara,Yuka Morita,Taichi Tamura,Yuya Atsuta,Ryosuke Konuma,Shohei Nakamura,Atsushi Wada,Toshihiro Okuya,A Kageyama,Daisuke Murakami,Shiori Nakashima,Yusuke Uchibori,Daishi Onai,Atsushi Sumitomo Spec Hamamura,Akihiko Nishijima,Yasushi Omuro,Naoki Shingai,T. Shimizuguchi,Takashi Toya,Hiroaki Shimizu,Yuho Najima,Takeshi Kobayashi,Kyoko Haraguchi,Kazuteru Ohashi,Noriko Doki,Yoshiki Okuyama,Tatsu Shimoyama +34 more
TL;DR: Tisagenlecleucel for diffuse large B-cell lymphoma (r/r DLBCL) was evaluated in this paper , where the CAR-T infusion showed high efficacy and manageable safety profile comparable with the pivotal trial.
Journal Article
Clinical Efficacy of mFOLFOX6 for Advanced Gastric Cancer
TL;DR: It is concluded that, unlike FP, FOLFOX is an effective therapy for of gastric cancer.
Journal ArticleDOI
Relative dose intensity of R-CHOP therapy and patient outcomes in advanced follicular lymphoma.
Tatsuya Konishi,Yusuke Kanemasa,Yuki Sasaki,Toshihiro Okuya,Tsukasa Yamaguchi,Chikako Funasaka,Tatsu Shimoyama,Yasushi Omuro +7 more
TL;DR: The impact of the relative dose intensity (RDI) of R‐CHOP on patient outcomes, when used as the initial treatment for advanced‐stage FL, is analyzed.